Literature DB >> 30337426

18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis.

Silvia Bellando-Randone1,2, Luca Tartarelli3, Edorardo Cavigli4, Lorenzo Tofani5, Cosimo Bruni6,2, Gemma Lepri6,2, Jelena Blagojevic6,2, Alberto Moggi-Pignone7, Carina Mihai8, Jerome Avouac9, Alessandro Passeri3, Maria Teresa De Cristofaro3, Oliver Distler8, Yannick Allanore9, Serena Guiducci6,2, Marco Matucci-Cerinic6,2.   

Abstract

Entities:  

Keywords:  Autoimmune Diseases; inflammation; systemic sclerosis

Mesh：

Substances：

Year:  2018        PMID： 30337426     DOI： 10.1136/annrheumdis-2018-213376

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  The race against time to disclose lung inflammation in interstitial lung disease in systemic sclerosis: is PET scan the winning solution?

Authors:  Silvia Bellando-Randone; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

2.  PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.

Authors:  Andréa L Bastos; Gilda A Ferreira; Marcelo Mamede; Eliane V Mancuzo; Mauro M Teixeira; Flávia P S T Santos; Cid S Ferreira; Ricardo A Correa
Journal:  J Bras Pneumol       Date:  2022-06-06       Impact factor: 2.800

3.  Circulating biomarkers of systemic sclerosis - interstitial lung disease.

Authors:  Anna-Maria Hoffmann-Vold; Håvard Fretheim; Chantal Meier; Britta Maurer
Journal:  J Scleroderma Relat Disord       Date:  2020-01-06

4.  The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.

Authors:  Daphne M Peelen; Ben G J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Otto S Hoekstra; Conny J Van der Laken; Alexandre E Voskuyl
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

5.  18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study.

Authors:  Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin
Journal:  Arthritis Res Ther       Date:  2021-03-06       Impact factor: 5.156

6.  Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation.

Authors:  Bo Broens; Conny J van der Laken; Gerben J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Julia Spierings; Jeska K de Vries-Bouwstra; Jacob M van Laar; Alexandre E Voskuyl
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

7.  18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study.

Authors:  Janine Schniering; Martina Benešová; Matthias Brunner; Stephanie Haller; Susan Cohrs; Thomas Frauenfelder; Bart Vrugt; Carol Feghali-Bostwick; Roger Schibli; Oliver Distler; Cristina Müller; Britta Maurer
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.